跳至主要内容
临床试验/NCT05643027
NCT05643027已完成不适用

A Novel Intervention for Avoidance-Related Opioid Misuse in Patients With Cancer

Dana-Farber Cancer Institute2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Feasibility of the intervention, defined as an enrollment rate of at least 60%

研究概览

简要总结

This research study is being done to develop an intervention for psychological symptoms that patients diagnosed with cancer may experience. Psychological symptoms may include thoughts, feelings, emotions, and memories

The names of the study intervention and research activities involved in this study are/is:

  • Acceptance & Commitment Therapy (ACT) for Cancer (involving 6 sessions with a licensed clinical psychologist)
  • Questionnaires
  • Post-study interview

Consistent with the NIH Stage Model for Behavioral Intervention Development, the investigators have adapted an existing, empirically-validated intervention, Acceptance and Commitment Therapy (ACT), to address substance use disorder risk during cancer care. The core components of ACT are particularly well-suited to address the psychological processes underlying opioid misuse in individuals treated for cancer pain. The overarching aim is to assess the feasibility and acceptability of the intervention by conducting a randomized pilot trial of the revised intervention ("ACTION") for cancer patients on opioid therapy, and at risk for SUD.

详细描述

This research study is a Feasibility Study, which is the first-time investigators are examining this psychological intervention in patients with cancer who are prescribed opioids and are receiving palliative care. This study is being conducted to develop a psychological intervention designed specifically for individuals with cancer. The purpose of this study is to determine how practical this intervention is, to determine patient satisfaction, and test the study procedures. The aims are to:

  1. determine whether this intervention will be appropriate for further testing;
  2. identify which parts of the protocol and procedures need to be modified; and
  3. assess patients' reactions to this intervention.

This research study involves a psychological intervention for thoughts, feelings, emotions, and memories that individuals diagnosed with cancer may have.

The names of the study intervention and research activities involved in this study are/is:

  • Acceptance & Commitment Therapy (ACT) for Cancer (involving 6 sessions with a licensed clinical psychologist)
  • Questionnaires
  • Post-study interview

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 18 years old
  • have an estimated survival time of at least 6 months (as estimated by palliative care provider)
  • score at least 4 on the Opioid Risk Tool (ORT)
  • have been diagnosed with any cancer, including hematologic malignancies
  • performance status criterion of 0, 1, or 2 [ with 0 indicating that the patient is asymptomatic, 1 that the patient is symptomatic but fully ambulatory, and 2 that the patient is symptomatic and in bed <50% of the day]

排除标准

  • Patients with a score at least 3 to ensure that all enrolled patients are able to participate in the intervention, complete assessments, ensure that no patients who are too sick to participate are enrolled; this will enhance the rigor of the study)
  • currently be on opioid therapy
  • not meet criteria for current substance use disorder
  • assessed by the Diagnostic & Statistical Manual of mental disorders; DSM-5 or be receiving substance use disorder treatment; and speak and comprehend English sufficiently to be able to participate in psychotherapy.

研究组 & 干预措施

INTERVENTION FOR AVOIDANCE-RELATED OPIOID MISUSE

Other

Participants will participate in a six-session behavioral intervention, delivered by a licensed clinical psychologist.

干预措施: Acceptance and Commitment Therapy (Behavioral)

结局指标

主要结局

Feasibility of the intervention, defined as an enrollment rate of at least 60%

时间窗: 1 year

enrollment rate of at least 60% and retention rate of at least 75%

Acceptability of the intervention, measured by Client Satisfaction Questionnaire (CSQ-8) scores

时间窗: 1 year

Acceptability of the intervention, measured by CSQ-8 scores and patient reported feedback during exit interviews. On the CSQ-8, some items are reverse scored but higher scores mean greater satisfaction. Min value = 8, max value = 32

次要结局

  • Depression, measured by the Patient Health Questionnaire (PHQ-9)(1 year)
  • anxiety, as measured by the Generalized Anxiety Disorder questionnaire (GAD-7)(1 year)
  • opioid misuse behaviors and consequences, as measured by the Current Opioid Misuse Measure (COMM)(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Miryam Yusufov, PhD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (2)

Loading locations...

相似试验

A Novel Intervention for Patients With Cancer | 临床试验